| |
MESSAGE _ENGLISH VERSION_
|
|
| |
The Management Board of Proguns Group S.A. with its registered office in Warsaw _the "Issuer"_ hereby announces that on 7th July 2026, the Issuer entered into a commercial representation agreement _the "Agreement"_ with Dillon Aero Incorporated, with its registered office in Arizona, USA _"Dillon Aero"_. Pursuant to the Agreement, the Issuer will act as Dillon Aero's representative in the territory of Poland in relation to activities concerning the offering and sales support of weapon systems manufactured by Dillon Aero, as well as components, ammunition systems, mounts, accessories, training, and logistical support related to such systems. The Agreement has been concluded for a period of two years and sets out detailed terms of cooperation between the parties, including the scope of the Issuer's representation activities, rules of communication with potential institutional customers, regulatory compliance obligations, and the principles of the Issuer's remuneration under a commission-based model. Detailed financial terms of the Agreement have not been disclosed to the public due to their commercially sensitive nature. Dillon Aero is a U.S.-based manufacturer of advanced Gatling-type weapon systems designed for integration with air, land, and maritime platforms. Its key products include, in particular, the M134D system chambered in 7.6251 mm NATO _Minigun_, used primarily as a fire-support weapon for helicopters, special-purpose vehicles, armored personnel carriers, and naval units, as well as the heavier 503D system chambered in 12.799 mm _.50 BMG_. Dillon Aero's products are intended primarily for institutional customers, including military, police, and other uniformed services. The Issuer indicates that the execution of the Agreement constitutes an element of the implementation of the Issuer's strategy aimed at building competencies in the area of distribution and commercial representation of weapon systems and related products, as announced in the strategy published on 12 March 2026 in ESPI current report No. 13/2026. In the Issuer's opinion, the execution of the Agreement may be of material importance for the further development of the Issuer's operations in the defense products segment. However, the Agreement's impact on the Issuer's future financial results will depend on the effectiveness of securing orders and completing transactions covered by the scope of cooperation.
|
|
|